B Conte-Devolx

Summary

Country: France

Publications

  1. ncbi request reprint [Molecular genetics in endocrinology]
    B Conte-Devolx
    Service d endocrinologie, diabète et maladies métaboliques, Hopital de la Timone, Marseille
    Ann Endocrinol (Paris) 66:289-91. 2005
  2. ncbi request reprint [Polyadenomatoses: type 2 multiple endocrine neoplasms]
    B Conte-Devolx
    Service d endocrinologie maladies métaboliques, Hôpital de la Timone 13385 Marseille
    Presse Med 31:1224-30. 2002
  3. ncbi request reprint [Multiple endocrine neoplasia type 2]
    B Conte-Devolx
    Service d endocrinologie, Diabète, Maladies Metaboliques, Hopital de la Timone, 13385 Marseille
    Ann Endocrinol (Paris) 64:389-92. 2003
  4. ncbi request reprint Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    D Taieb
    Service Central de Biophysique et de Medecine Nucleaire, Centre Hospitalo Universitaire de la Timone, Marseille, France
    Clin Endocrinol (Oxf) 61:102-8. 2004
  5. doi request reprint Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients
    A Begu-Le Corroller
    Service de nutrition maladies métaboliques endocrinologie, Hopital de la Timone, 264, rue Saint Pierre, 13005 Marseille, France
    Diabetes Metab 34:343-8. 2008
  6. ncbi request reprint [RET mutations and preventive treatment of medullary thyroid cancer]
    P Niccoli-Sire
    Faculte de Medecine de Marseille, Universite de la Mediterranee, Assistance Publique Hôpitaux de Marseille Hôpital de la Timone, Service d endocrinologie, 13385 Marseille Cedex 05
    Ann Endocrinol (Paris) 66:168-75. 2005
  7. ncbi request reprint [Medullary thyroid carcinoma]
    P Niccoli-Sire
    Service d endocrinologie, diabète et maladies métaboliques, Assistance Publique Hopitaux de Marseille, Faculte de Medecine de Marseille, Universite de la Mediterranee, CHU de la Timone, 13385 Marseille Cedex 05, France
    Ann Endocrinol (Paris) 68:325-31. 2007
  8. ncbi request reprint [Multiple endocrine neoplasia type 2]
    P Niccoli-Sire
    Service d endocrinologie, Diabète, Maladies Metaboliques, CHU de la Timone, Faculte de Medecine de Marseille, Universite de la Mediterranee, Assistance Publique Hopitaux de Marseille, Marseille, France
    Ann Endocrinol (Paris) 68:317-24. 2007
  9. doi request reprint Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
    F Castinetti
    Department of Endocrinology, Diabetes, Metabolic Diseases and Nutrition, Hopital de la Timone, Centre Hospitalier Universitaire de Marseille and Faculté de Médecine, Universite de la Mediterranee, 264 rue St Pierre, Cedex 5, 13385 Marseille, France
    Eur J Endocrinol 158:91-9. 2008
  10. ncbi request reprint Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome
    F Castinetti
    Federation of Endocrinology, Diabetes, Metabolic Diseases and Nutrition, Hopital de la Timone, Centre Hospitalier Universitaire de Marseille, Marseille, France
    Eur J Endocrinol 157:271-7. 2007

Collaborators

Detail Information

Publications13

  1. ncbi request reprint [Molecular genetics in endocrinology]
    B Conte-Devolx
    Service d endocrinologie, diabète et maladies métaboliques, Hopital de la Timone, Marseille
    Ann Endocrinol (Paris) 66:289-91. 2005
  2. ncbi request reprint [Polyadenomatoses: type 2 multiple endocrine neoplasms]
    B Conte-Devolx
    Service d endocrinologie maladies métaboliques, Hôpital de la Timone 13385 Marseille
    Presse Med 31:1224-30. 2002
    ..Biological explorations in all persons carrying this mutation would permit diagnosis and surgical treatment of the endocrine lesions, before their clinical manifestation...
  3. ncbi request reprint [Multiple endocrine neoplasia type 2]
    B Conte-Devolx
    Service d endocrinologie, Diabète, Maladies Metaboliques, Hopital de la Timone, 13385 Marseille
    Ann Endocrinol (Paris) 64:389-92. 2003
  4. ncbi request reprint Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    D Taieb
    Service Central de Biophysique et de Medecine Nucleaire, Centre Hospitalo Universitaire de la Timone, Marseille, France
    Clin Endocrinol (Oxf) 61:102-8. 2004
    ..To assess the impact of [(131)I]meta-iodobenzylguanidine ((131)MIBG) scintigraphy on the management of phaeochromocytoma...
  5. doi request reprint Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients
    A Begu-Le Corroller
    Service de nutrition maladies métaboliques endocrinologie, Hopital de la Timone, 264, rue Saint Pierre, 13005 Marseille, France
    Diabetes Metab 34:343-8. 2008
    ....
  6. ncbi request reprint [RET mutations and preventive treatment of medullary thyroid cancer]
    P Niccoli-Sire
    Faculte de Medecine de Marseille, Universite de la Mediterranee, Assistance Publique Hôpitaux de Marseille Hôpital de la Timone, Service d endocrinologie, 13385 Marseille Cedex 05
    Ann Endocrinol (Paris) 66:168-75. 2005
  7. ncbi request reprint [Medullary thyroid carcinoma]
    P Niccoli-Sire
    Service d endocrinologie, diabète et maladies métaboliques, Assistance Publique Hopitaux de Marseille, Faculte de Medecine de Marseille, Universite de la Mediterranee, CHU de la Timone, 13385 Marseille Cedex 05, France
    Ann Endocrinol (Paris) 68:325-31. 2007
    ..Ten-year survival is about 80% when the patients are not surgically cured and reaches 95% when the biological marker CT is normalized after surgery...
  8. ncbi request reprint [Multiple endocrine neoplasia type 2]
    P Niccoli-Sire
    Service d endocrinologie, Diabète, Maladies Metaboliques, CHU de la Timone, Faculte de Medecine de Marseille, Universite de la Mediterranee, Assistance Publique Hopitaux de Marseille, Marseille, France
    Ann Endocrinol (Paris) 68:317-24. 2007
    ..Prognosis of MEN2 is mainly related to the stage-dependant prognosis of MTC, thus pointing the necessity of a complete thyroid surgery for index cases with MTC and the earliest thyroidectomy for screened at risk subjects...
  9. doi request reprint Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
    F Castinetti
    Department of Endocrinology, Diabetes, Metabolic Diseases and Nutrition, Hopital de la Timone, Centre Hospitalier Universitaire de Marseille and Faculté de Médecine, Universite de la Mediterranee, 264 rue St Pierre, Cedex 5, 13385 Marseille, France
    Eur J Endocrinol 158:91-9. 2008
    ..Adjunctive treatments each have specific drawbacks. Despite its inhibitory effects on steroidogenesis, the antifungal drug ketoconazole was only evaluated in series with few patients and/or short-term follow-up...
  10. ncbi request reprint Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome
    F Castinetti
    Federation of Endocrinology, Diabetes, Metabolic Diseases and Nutrition, Hopital de la Timone, Centre Hospitalier Universitaire de Marseille, Marseille, France
    Eur J Endocrinol 157:271-7. 2007
    ..Our objective was to determine sensitivity and specificity of desmopressin test during petrosal sinus sampling...
  11. ncbi request reprint [Management of asymptomatic primary hyperparathyroidism: French Society of Endocrinology expert consensus]
    M Calzada-Nocaudie
    Service dEndocrinologie, Unité 62, CHU de Reims, Hopital Robert Debre, Reims
    Ann Endocrinol (Paris) 67:7-12. 2006
  12. ncbi request reprint [Primary hyperparathyroidism: before and during surgery]
    B Conte-Devolx
    Service d endocrinologie, Hopital de la Timone, 13385 Marseille Cedex 5
    Ann Endocrinol (Paris) 66:69-72. 2005
  13. doi request reprint Motesanib diphosphate in progressive differentiated thyroid cancer
    Steven I Sherman
    Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M D Anderson Cancer Center, Houston 77230 1402, USA
    N Engl J Med 359:31-42. 2008
    ..Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT...